Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. University of Turin, Turin, Italy

Survival: 8.5 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: Italy
City/State/Province: Turin
Hospital: University of Turin
Journal: Link
Date: 11/2009

Patients: This phase 2 study involved 47 patients with advanced non-small cell lung cancer. Their median age was 60, ranging from 37 to 81 years of age. There were 27 men and 20 women.

Treatment: Patients were treated with the biological therapy sunitinib.

Toxicity: Seven patients died while on the study. Four died from disease or worsening health, one died of a pulmonary embolism, one from treatment-related congestive heart failure, and one from disease progression and pulmonary embolism.

Results: The median overall survival was 8.5 months (37.1 weeks).

Support: This study was supported by research funds from Pfizer, which markets sunitinib as SUTENT.

Correspondence: Dr. Silvia Novello

E-mail to a Friend Email Physician More Information